These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Influence of lanreotide on uptake of Aalbersberg EA; de Wit-van der Veen BJ; Versleijen MWJ; Saveur LJ; Valk GD; Tesselaar MET; Stokkel MPM Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):696-703. PubMed ID: 30097670 [TBL] [Abstract][Full Text] [Related]
5. The DEXA-CORT trial: study protocol of a randomised placebo-controlled trial of hydrocortisone in patients with brain tumour on the prevention of neuropsychiatric adverse effects caused by perioperative dexamethasone. Koning ACAM; Satoer DD; Vinkers CH; Zamanipoor Najafabadi AH; Biermasz NR; Nandoe Tewarie RDS; Moojen WA; van Rossum EFC; Dirven CMF; Pereira AM; van Furth WR; Meijer OC BMJ Open; 2021 Dec; 11(12):e054405. PubMed ID: 37057711 [TBL] [Abstract][Full Text] [Related]
6. PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study. Wang H; Hou B; Lu L; Feng M; Zang J; Yao S; Feng F; Wang R; Li F; Zhu Z J Nucl Med; 2018 Mar; 59(3):523-528. PubMed ID: 28775202 [TBL] [Abstract][Full Text] [Related]
7. [ Pauwels E; Cleeren F; Tshibangu T; Koole M; Serdons K; Dekervel J; Van Cutsem E; Verslype C; Van Laere K; Bormans G; Deroose CM Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3033-3046. PubMed ID: 32617641 [TBL] [Abstract][Full Text] [Related]
8. CXCR4-directed [ Chaman Baz AH; van de Wiel E; Groenewoud H; Arntz M; Gotthardt M; Deinum J; Langenhuijsen J BMJ Open; 2022 Aug; 12(8):e060779. PubMed ID: 35998969 [TBL] [Abstract][Full Text] [Related]
9. Value of the Fastrez M; Artigas C; Sirtaine N; Wimana Z; Caillet M; Rozenberg S; Flamen P Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():69-74. PubMed ID: 28342392 [TBL] [Abstract][Full Text] [Related]
10. Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1). Lastoria S; Marciello F; Faggiano A; Aloj L; Caracò C; Aurilio M; D'Ambrosio L; Di Gennaro F; Ramundo V; Camera L; De Luca L; Fonti R; Napolitano V; Colao A Endocrine; 2016 Jun; 52(3):488-94. PubMed ID: 26242621 [TBL] [Abstract][Full Text] [Related]
11. The use of (68)Ga DOTATATE PET/CT for diagnostic assessment and monitoring of (177)Lu DOTATATE therapy in pituitary carcinoma. Novruzov F; Aliyev JA; Jaunmuktane Z; Bomanji JB; Kayani I Clin Nucl Med; 2015 Jan; 40(1):47-9. PubMed ID: 25275413 [TBL] [Abstract][Full Text] [Related]
12. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin. Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074 [TBL] [Abstract][Full Text] [Related]
13. Ectopic Thyroid-Stimulating Hormone-Secreting Pituitary Adenoma of the Nasopharynx Diagnosed by Gallium 68 DOTATATE Positron Emission Tomography/Computed Tomography. Kim S; Dillon WP; Hope TA; El-Sayed IH; van Zante A; Wu K; Masharani U World Neurosurg; 2019 May; 125():400-404. PubMed ID: 30797906 [TBL] [Abstract][Full Text] [Related]